Should I do chemotherapy before or after surgery for Chordoma

Chemotherapy Timing for Chordoma: What You Should Know

This is an important question, and I want to help you understand how doctors approach this decision. However, I need to be clear: the timing of chemotherapy relative to surgery for chordoma is a decision that requires your specific medical team's expertise, as it depends on many factors unique to your case.

How Doctors Think About This Decision

Oncologists and surgeons consider several factors when deciding whether to give chemotherapy before surgery (neoadjuvant), after surgery (adjuvant), or both:

Before Surgery (Neoadjuvant Chemotherapy):

• May shrink the tumor to make surgery easier or more complete
• Allows doctors to see how your tumor responds to treatment
• Might improve the chances of removing all the cancer

After Surgery (Adjuvant Chemotherapy):

• Targets any cancer cells that may have spread beyond what surgery removed
• Allows surgeons to operate first without delay
• Timing depends on how well you recover from surgery

The Challenge with Chordoma Specifically: Chordoma is a rare tumor, which means there's less published research compared to common cancers. Treatment approaches are often individualized based on:

• The tumor's location (spine, sacrum, base of skull)
• Whether it's newly diagnosed or recurrent
• How large it is and whether it's affecting nearby structures
• Your overall health and ability to tolerate treatment

Questions to Ask Your Oncology and Surgical Team

Since the available guidelines don't provide a one-size-fits-all answer for chordoma, ask your doctors:

1. "Based on my tumor's size, location, and stage, do you recommend chemotherapy before or after surgery—and why?"

2. "What would neoadjuvant chemotherapy accomplish in my case? Would it make surgery safer or more complete?"

3. "Are there clinical trials for chordoma that might inform the best sequencing for my situation?"

4. "How will we monitor whether the chemotherapy is working if we do it before surgery?"

5. "What are the risks and benefits of each approach for my specific case?"

Important Context

Because chordoma is rare, your care team may be drawing on:

• Their experience with similar cases
• Published case reports and small studies
• Multidisciplinary tumor board discussions (where surgeons, oncologists, and radiologists collaborate)
• Specialized chordoma centers or networks

This collaborative approach is actually a strength—it means your team is thinking carefully about YOUR specific situation rather than applying a standard protocol.

Next Steps

I'd recommend:

• Asking your team if they've consulted with a chordoma specialist or center of excellence
• Requesting a second opinion from another chordoma specialist if you want additional perspective
• Asking about any clinical trials that might be relevant to your case

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.